Biogennix Agilon Moldable Bone Graft Available Throughout the U.S.

Biogennix Agilon® Moldable grafting product is now available throughout the U.S. The collagen-enhanced product has seen steady month-after-month growth in sales since its launch two years ago, with a surge in popularity and usage in 2021, largely driven by its positive reception from the foot and ankle surgery community.

Agilon Moldable is the only moldable synthetic bone graft that contains both collagen and carrier, providing ease of handling right out of the box without hydration. Agilon Moldable is packed with Biogennix’s proprietary TrelCor™ granules, which feature a biologically active layer of nanocrystalline hydroxycarbanoapatite that promotes cellular healing immediately upon implantation.

“It’s been very rewarding to see Agilon Moldable be so well received by the foot and ankle surgery community,” said Scott Bauccio, Vice President of Sales and Business Development for Biogennix. “They really appreciate how well the product handles and stays together when packing into tight defects. We expect to see continued exponential growth in this specialty as well as with the spine and general orthopedics communities where we are already well established.”